Floatz logo

Goserelin

Female Breast Carcinoma

Ahon Pharmaceutical Co., Ltd.protein_peptidePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Female Breast Carcinoma cohort.

Asset / SponsorPhaseRating
ANASTROZOLE
Ahon Pharmaceutical Co., Ltd.
Phase 4BBB
PROPOFOL
Tata Memorial Centre
Phase 4BB
Sevoflurane
Tata Memorial Centre
Phase 4BB
TOREMIFENE
Peking Union Medical College Hospital
Phase 4BB
FULVESTRANT
Ahon Pharmaceutical Co., Ltd.
Phase 3BB

View all 21 →

Same molecule, other indications

Goserelin is also rated in:

breast cancerActive
BB
Indicative · Phase 4
70 / 100
View asset →
prostate carcinomaActive
BB
Indicative · Phase 3
69 / 100
View asset →
prostate adenocarcinomaActive
BB
Indicative · Phase 3
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →